Workflow
Bowman to Attend June Investor Conferences
GlobeNewswire· 2025-05-22 11:30
RESTON, Va., May 22, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, announced it will participate in the following June investor conferences: Stifel 2025 Cross Sector 1x1 Conference, held June 3-4 in Boston, MA15th Annual ROTH London Conference, held June 24-26 in London, UK About Bowman Consulting Group Ltd.Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technolog ...
Plato Gold Reports on First Quarter Results
GlobeNewswire· 2025-05-22 11:30
Toronto, ON, May 22, 2025 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is pleased to report the three months financial results for fiscal 2025 and 2024, as summarized below: Three Months Ended (Unaudited) March 31, March 31, 2025 2024 Income $ - $ 513 Net Loss and Comprehensive Loss $ 29,969 $ 52,664 Loss per ...
Repligen Corporation to Present at William Blair Growth Conference
GlobeNewswire· 2025-05-22 11:30
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the William Blair 45th Annual Growth Stock Conference being held June 3 – 5 in Chicago. Olivier Loeillot, President and Chief Executive Officer is scheduled to present a company overview on June 3rd at 1:20 p.m. CT. A live webcast of the conference presentation will be accessible through Repligen’s Invest ...
Investeringsforeningen Nykredit Invest Balance ophæver suspension af udvalgte afdelinger
GlobeNewswire· 2025-05-22 11:28
I forlængelse af tidligere meddelelse d. 22. maj 2025 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves. Ophævelsen gælder nedenstående afdelinger: Fund NameISINOrder Book CodeDefensiv KLDK0016188733NBIDEKLModerat KLDK0016188816NBIMOKLOffensiv KLDK0060441749NBIOFKL Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk ell ...
Aurora Spine Corporation Announces Record First Quarter Financial Results
GlobeNewswire· 2025-05-22 11:15
Core Insights - Aurora Spine Corporation reported its best first quarter on record for fiscal 2025, with a revenue increase of 10.0% year-over-year, reaching $4.42 million [3][4][7]. Financial and Business Highlights - The company achieved record Q1 revenue of $4,417,027, an increase of $403,226 compared to $4,013,801 in Q1 2024 [4][7]. - Gross margin for Q1 2025 was 58.0%, down from 61.9% in Q1 2024, attributed to increased shipping costs and higher distributor commissions [8]. - Operating expenses rose to $2.90 million in Q1 2025 from $2.75 million in Q1 2024, primarily due to increased compensation and training expenses [9]. - The net loss for Q1 2025 was $(0.350) million, compared to a loss of $(0.267) million in Q1 2024 [11]. Management Commentary - The CEO highlighted the success of proprietary product platforms, particularly the SiLO-TFX system and ZIP-51, which enhance spinal surgery outcomes [3]. - Future growth is anticipated to exceed 20% in fiscal 2025, driven by R&D investments and the launch of new products, including the DEXA-L series and AERO™ [3]. - The CFO emphasized the company's focus on maintaining tight expense controls while capitalizing on growth opportunities [5]. Product Developments - The FDA granted 510(k) clearance for the AERO™ Facet Fusion System, marking a significant milestone for the company [4]. - The DEXA-C cervical implant sales increased by $204K year-over-year, indicating a renewed focus on the cervical spine market [4]. - The company is preparing for the launch of the DEXA-L and AERO products, which are expected to enhance its product portfolio [3][4]. Selected Financial Position Information - As of March 31, 2025, total assets were $11,754,003, with cash at $488,693 and receivables at $4,098,086 [13][14]. - Current liabilities increased to $4,263,792 from $3,884,233 at the end of 2024 [14]. Selected Quarterly Information - The company reported a gross profit of $2,562,783 for Q1 2025, with operating expenses of $2,879,114 [16]. - EBITDAC for Q1 2025 was $(20,924), a slight improvement from $(320,362) in Q1 2024 [16].
NexGold Receives Cabinet Approval for the Crown Land Lease at the Goldboro Gold Project
GlobeNewswire· 2025-05-22 11:15
Core Viewpoint - NexGold Mining Corp. has received approval for the Crown Land Lease and License for the Goldboro Gold Project, marking a significant milestone for the company's development efforts in Nova Scotia [1][2][3]. Group 1: Project Development - The Crown Land Lease and License are essential for the development of the Goldboro Gold Project, allowing for infrastructure development and the operation of an open pit mine [2][3]. - The lease covers an area of 779 hectares, while the license encompasses an additional 97 hectares of Crown land [2]. Group 2: Economic Impact - The Goldboro Gold Project is expected to create over 700 jobs and contribute approximately $2.1 billion to Nova Scotia's economy over its lifetime [3]. - Gold has been added to Nova Scotia's strategic minerals list, indicating government support for projects like Goldboro [3]. Group 3: Company Overview - NexGold Mining Corp. focuses on gold mining with assets in Canada and Alaska, including the Goliath Gold Complex in Ontario and the Goldboro Gold Project in Nova Scotia [4]. - The company is committed to engaging with regional communities and Indigenous Nations to create sustainable economic opportunities and promote community well-being [4].
The Joint Corp. Announces Christopher M. Grandpre Elected as Director
GlobeNewswire· 2025-05-22 11:05
Core Insights - The Joint Corp. has elected Christopher M. Grandpre to its board of directors to support long-term growth objectives including new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA [1][2] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S. through The Joint Chiropractic network, focusing on making chiropractic care accessible and affordable without the need for insurance [5] - The company operates over 950 locations nationwide and has more than 14 million patient visits annually, positioning itself as a leader in the chiropractic industry [5] Leadership and Expertise - Christopher M. Grandpre brings over 30 years of experience in multi-branded franchise companies and M&A investment banking, having served as chairman of Empower Brands, which has sales exceeding $1.5 billion [3][4] - Grandpre's background includes founding Outdoor Living Brands and holding executive roles at various financial institutions, providing a unique perspective to The Joint's leadership [3][4] Business Model and Strategy - The Joint Corp. revolutionized chiropractic care access with its retail healthcare business model introduced in 2010, focusing on convenience and affordability for patients [5] - The company is recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500," highlighting its growth and innovation in the franchise sector [5]
Accelsius Joins ARPA-E COOLERCHIPS Project to Advance Hybrid Cooling Technologies for the Data Center of the Future
GlobeNewswire· 2025-05-22 11:00
Group 1: Project Overview - Accelsius has been selected as a key contributor to the U.S. Department of Energy's ARPA-E COOLERCHIPS project, focusing on developing a next-generation hybrid cooling architecture for data centers [1][3] - The project aims to reduce total cooling energy consumption to less than 5% of a data center's IT load while maintaining reliability and enabling high-density computing [3] Group 2: Technology and Contributions - Accelsius will provide its proprietary MR250, a multi-rack, in-row, 250kW two-phase Coolant Distribution Unit (2P CDU), for system-level testing at the UT Arlington campus [2] - The MR250 is expected to be generally available by late 2025, enhancing the project's test infrastructure [2] Group 3: Collaboration and Impact - The collaboration between Accelsius and The University of Texas at Arlington is expected to advance the understanding and benchmarking of two-phase, direct-to-chip cooling technologies [3][4] - Industry leaders express excitement about the potential impact of this collaboration on U.S. leadership in next-generation data center efficiency [4] Group 4: Company Background - Accelsius, founded by Innventure, Inc. (NASDAQ:INV), specializes in advanced cooling solutions that help data center and edge operators achieve business, financial, and sustainability goals [5] - The company's NeuCool platform offers best-in-class thermal efficiencies through a safe, two-phase liquid cooling system scalable from single racks to entire data centers [5]
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes
GlobeNewswire· 2025-05-22 11:00
Core Insights - Sernova Biotherapeutics has formed a Clinical Advisory Board to guide the development of its Cell Pouch Bio-hybrid Organ as a potential functional cure for type 1 diabetes (T1D) [1][7] Group 1: Clinical Advisory Board Composition - The board consists of five members, chaired by Dr. Robert Gabbay, who has extensive experience in diabetes care and research [2] - Other notable members include: - Dr. Mark Atkinson, a leading researcher in T1D with over 750 publications [3] - Dr. Melena Bellin, an expert in islet cell transplantation for T1D [4] - Dr. Andrew Posselt, a surgeon-scientist specializing in transplant immunology [5] - Dr. Holger Russ, who focuses on regenerative medicine and autoimmune type 1 diabetes [6] Group 2: Company Overview and Technology - Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics, specifically the Cell Pouch integrated with human donor cells or stem-cell derived islet-like clusters [8] - The Cell Pouch is designed to create bio-hybrid organs that restore or enhance organ function, initially targeting T1D and thyroid disorders [9]
Lantronix Awarded 2025 TMC Labs Innovation Award for Its SmartLV IoT Cellular Gateway
GlobeNewswire· 2025-05-22 11:00
Core Insights - Lantronix Inc. has been awarded the 2025 TMC Labs Innovation Award for its SmartLV IoT cellular gateway, which is recognized as the first AI-enabled IoT Edge Compute Cellular Gateway powered by the Qualcomm IQ-615 processor [1][2][3] Company Overview - Lantronix is a global leader in compute and connectivity IoT solutions, focusing on high-growth markets such as Smart Cities, Enterprise, and Transportation [6] - The company emphasizes innovation and has a long-term partnership with Qualcomm to deliver advanced IoT solutions [3][6] Product Features - The SmartLV is designed for low-voltage substations and distribution automation applications, aimed at enhancing real-time visibility, control, and automation in the energy sector [4] - It incorporates advanced cybersecurity protocols and AI capabilities, ensuring secure operations for mission-critical applications [5] - The gateway provides Distribution System Operators (DSOs) with the ability to control energy distribution precisely when and where needed [4][5][6]